Mingrui Wu Lan Liang Xiaotian Dai
10.3389/fonc.2022.939022
Front Oncol
2022 Aug 3;12:939022.
immune checkpoint inhibitors immunotherapy prognostic biomarker treatment efficacy tumor mutation burden (tmb)
CC BY
https://pubmed.ncbi.nlm.nih.gov/35992799/
Case Reports
PMC9381827
35992799
Discussion of tumor mutation burden as an indicator to predict efficacy of immune checkpoint inhibitors: A case report
2022